Company profilePharmaceutical#94 of 1,318 in Pakistan✓ No DRAP alerts

UNEXO LABS (PVT) LTD.

Pharmaceutical company · 172 brands · 165 molecules

Ranked #17 of 50 companies in Antimalarials

172 registered products 85 pharmaceutical brands 165 distinct molecules 0 DRAP alerts

Company overview

172
registered products
85
pharmaceutical brands
165
distinct molecules
1
therapeutic classes
0
DRAP alerts

UNEXO LABS (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 172 product registrations across 165 distinct molecules. It is the 94th largest registrant in Pakistan by product count, and ranks 17th of 50 in Antimalarials. Its portfolio is concentrated in Antimalarials. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by UNEXO

76 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Macrolides, Lincosamides And Streptogramins 2
Drugs For Obstructive Airway Diseases, Systemic 1

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

75
ceilings with an approval date
0
not revised in 2+ years
2026
oldest approval year
202675

Top molecules by brand count

Rifampicin15 brands
Isoniazid15 brands
Ethambutol9 brands
Pyrazinamide7 brands
Amoxicillin6 brands
Ampicillin6 brands
Paracetamol5 brands
Chloroquine4 brands
Cefixime4 brands

Therapeutic classes

Antimalarials · 2

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official151 products · Rs 3.71 – Rs 4,081.2
Median across source: Rs 412.79

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Wilshire Laboratories (Private) Limited holds 112 molecules not in this portfolio
AcyclovirAcyclovir SodiumAlfacalcidolAmoxycillinAnastrozoleArtemether
IRZA PHARMA (PVT) LTD. holds 94 molecules not in this portfolio
AcetazolamideAcyclovirAdrenalineAlbendazoleAmikacinAmoxycillin
ZAFA PHARMACEUTICAL LABORATORIES (PVT) LTD. holds 123 molecules not in this portfolio
AmikacinAmlodipine BaseAmmonium ChlorideAmmonium Chloride Containing ExpectorantsAmodiaquine BaseArtemether

Get the full profile for UNEXO

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.